MAYWOOD, IL – Loyola University Chicago Health Sciences Division has received a $50,000 infrastructure grant from St. Baldrick’s Foundation to support pediatric cancer clinical trials.
The grant will help fund a research nurse who coordinates clinical trials of new drugs and drug combinations and new regimens designed to minimize side effects, said Charles Hemenway, MD, PhD, division director of pediatric hematology/oncology of Loyola Medicine and Loyola University Chicago Stritch School of Medicine and the Ronald McDonald House Charities endowed professor in pediatric oncology.
“We are extremely grateful for this generous grant, which will enable us to make more clinical trials available to our patients,” Dr. Hemenway said. “Because government funding is limited, private funding from organizations such as St. Baldrick’s Foundation plays a critical role in advancing the treatment of children with cancer.”
Loyola is among 40 childhood cancer institutions across the country that received infrastructure grants from St. Baldrick’s.
“St. Baldrick’s Foundation is thrilled to fund this latest round of grants, which provides pediatric cancer treatments across the U.S. with the critical support they need to find cures and better treatments,” said St. Baldrick’s CEO Kathleen Ruddy. “With these funds these institutions will be able to enroll more children on lifesaving clinical trials, and complete the studies that are currently in progress. We are very thankful for our dedicated volunteers and donors who make these grants possible.”
The St. Baldrick’s Foundation is the largest private funder of childhood cancer research grants. St. Baldrick’s funds some of the most brilliant childhood cancer research experts in the world who are working to find cures and better treatments for all childhood cancers.